Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
Subject
Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine
Reference52 articles.
1. Psoriasis
2. WHO. World psoriasis day-document EB133.R2, agenda item 6.2. 2013. https://apps.who.int/gb/ebwha/pdf_files/EB133/B133_R2-en.pdf. Accessed May 14, 2020
3. Psoriasis causes as much disability as other major medical diseases
4. Psoriasis
5. Etiology and Pathogenesis of Psoriasis
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献